Jiangsu
China
9
2022-04-21
9
2025-04-08
These are the the leading inventors for applications assigned to Nanjing GenScript Biotech Co., Ltd.:
Nanjing GenScript Biotech Co., Ltd. based in Jiangsu, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Humanized anti-human OX40 monoclonal antibody, preparation method therefor and use thereof
#2 | 2022-03-10 ✅ Patent 12,098,204 granted on 2024-09-24Humanized anti-human PD-L1 monoclonal antibody and preparation method therefor and use thereof
#3 | 2021-12-16 ✅ Patent 12,173,273 granted on 2024-12-24Large-scale magnetic purification system
#4 | 2021-09-30 ✅ Patent 12,037,396 granted on 2024-07-16Humanized anti-human CTLA4 monoclonal antibody, preparation method therefor and use thereof
#5 | 2021-09-30 ✅ Patent 12,226,784 granted on 2025-02-18Magnetic bead purification system
#6 | 2021-03-11 ✅ Patent 11,260,400 granted on 2022-03-01Inclined magnetic holder
#7 | 2020-10-08 ✅ Patent 11,970,537 granted on 2024-04-30Fusion protein dimer using antibody Fc region as backbone and use thereof
#8 | 2020-04-30 ✅ Patent 11,313,829 granted on 2022-04-26Rapid blotting device and applications thereof
#9 | 2019-12-12 ✅ Patent 11,254,906 granted on 2022-02-22Automatic purification system and biological sample purification method
Also check out Nanjing GenScript Biotech Co., Ltd.'s (Jiangsu, China) applicant profile with 6 patent applications submitted.
372815 ⎘